For comprehensive information on potential issues, see the copper peptides side effects guide
These mandates include precise instructions regarding usage duration, storage temperature, and vial handling to safeguard product quality
For experiments FOXO4-DRI was dissolved in DMEM to generate a 2.5 mM stock solution
Maintaining BWFI integrity ensures the reliability of downstream applications
Third-party tested, with a Certificate of Analysis (CoA) available on request to support method development, analytical characterisation, and laboratory reference applications
It is not approved for human consumption, medical treatment, diagnostic use, or veterinary application